Eppendorf Says it Gets Import Ban on Nanosphere Products in EU, Germany | GenomeWeb

This article has been updated from a previous version to include comments from Nanosphere.

NEW YORK (GenomeWeb News) – Eppendorf said today that it has initiated an import ban against molecular diagnostics workstations and kits sold by Nanosphere because they allegedly infringe patents owned by Eppendorf that relate to microarray-based products.

The import ban covers any and all imports of Northbrook, Ill.-based Nanosphere's Verigene and Verigene SP systems into any country of the European Union, Eppendorf said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: peanut subgenome progenitor sequence, homozygosity mapping and linkage analyses using exome data, and more.

Tech companies like Microsoft are looking into DNA as a data storage device, Scientific American writes.

The New York Times writes that the Max Planck Institute for Infection Biology's Emmanuelle Charpentier has always been on the move, though now it's more about CRISPR.

The European Union calls for all publicly funded scientific papers to be immediately freely accessible to the public by 2020.